Weight Gain Outcomes Following Surgical Management of Laryngomalacia in Pediatric Patients: A Systematic Review
Main Article Content
Abstract
Laryngomalacia is the most common congenital upper airway disorder in infants, characterized by dynamic
supraglottic collapse, causing inspiratory stridor, feeding difficulties, and failure to thrive (FTT). While mild
cases resolve spontaneously, severe cases often require surgical intervention. Supraglottoplasty, the gold-
standard surgical treatment, alleviates airway obstruction, improves feeding efficiency, and promotes weight
gain. However, outcome variability and methodological differences highlight the need for a systematic review.
This review evaluates supraglottoplasty’s efficacy and safety in severe laryngomalacia, focusing on weight
gain, feeding efficiency, respiratory improvement, and complications. Following Preferred Reporting Items for
Systematic Reviews and Meta-Analyses guidelines, PubMed and Cochrane Library were systematically searched
for studies on pediatric patients undergoing supraglottoplasty. Data on weight gain, feeding, respiratory outcomes,
and complications were extracted, and quality was assessed using the Newcastle–Ottawa scale. Thirteen studies
(706 patients) were included. Mean age at surgery ranged from 2 weeks to 15.6 months. Weight gain improved
significantly, with percentile increases of 15–26 points, particularly in infants <6 months. Feeding efficiency
improved in 96% of cases, and respiratory symptoms resolved in >90%. Complication rates were low (<5%), with
transient dysphagia being most common. No major adverse events were reported. Supraglottoplasty effectively
improves weight gain, feeding, and respiratory outcomes in severe laryngomalacia, with a strong safety profile.
Early intervention is crucial for optimal growth, especially in FTT cases. Further research, including randomized
trials, is needed to standardize outcomes and refine techniques for complex cases
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.